Literature DB >> 2702093

Enhanced clearance of vancomycin by hemodialysis in a child.

R Schoumacher1, R L Chevalier, R A Gomez, A D Rogol, R Cummings, D A Spyker.   

Abstract

Clearance of vancomycin by hemodialysis has previously been reported to be negligible. We describe a child undergoing chronic hemodialysis using a hollow fiber dialyzer with cellulose acetate membrane. When the patient was treated with intravenous vancomycin for staphylococcal bacteremia, the serum vancomycin half-life was found to decrease by more than 90% during each course of hemodialysis. We conclude that, contrary to prevailing opinion, vancomycin can be rapidly cleared by hemodialysis in the small pediatric patient, and that the dosage should be adjusted accordingly.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2702093     DOI: 10.1007/BF00859632

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  5 in total

1.  Staphylococcal sepsis in patients on chronic hemodialysis regimens: intravenous treatment with vancomycin given once weekly.

Authors:  C G Barcenas; T J Fuller; J Elms; R Cohen; M G White
Journal:  Arch Intern Med       Date:  1976-10

2.  Pharmacokinetics of vancomycin in anuria.

Authors:  B A Cunha; R Quintiliani; J M Deglin; M W Izard; C H Nightingale
Journal:  Rev Infect Dis       Date:  1981 Nov-Dec

3.  Persistence of vancomycin in the blood during renal failure and its treatment by hemodialysis.

Authors:  D D Lindholm; J S Murray
Journal:  N Engl J Med       Date:  1966-05-12       Impact factor: 91.245

Review 4.  Vancomycin revisited.

Authors:  F V Cook; W E Farrar
Journal:  Ann Intern Med       Date:  1978-06       Impact factor: 25.391

5.  Vancomycin serum levels and toxicity in chronic hemodialysis patients with Staphylococcus aureus bacteremia.

Authors:  H Masur; P Francioli; M Ruddy; H W Murray
Journal:  Clin Nephrol       Date:  1983-08       Impact factor: 0.975

  5 in total
  2 in total

Review 1.  Critical care in uraemic children.

Authors:  J U Leititis; M Brandis
Journal:  Pediatr Nephrol       Date:  1992-01       Impact factor: 3.714

2.  Pharmacokinetics of Vancomycin in Pediatric Patients Receiving Intermittent Hemodialysis or Hemodiafiltration.

Authors:  Erin Chung; James A Tjon; Rosaleen M Nemec; Nadya Nalli; Elizabeth A Harvey; Christoph Licht; Winnie Seto
Journal:  Kidney Int Rep       Date:  2021-02-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.